Unapproved products may not have the same testing, labeling, purity standards, or adverse-event monitoring expected for approved prescription medications
CrossRef Value of des-gamma-carboxy prothrombin in comprehensive management of hepatocellular carcinoma Zi-Han Liu, Wen-Jun Wang, Shuang-Suo Dang World Chinese Journal of Digestology .2026
This is crucial timing for optimization
Malavazos AE, Iacobellis G, Dozio E, Basilico S, Di Vincenzo A, Dubini C, et al
In line with evidence accrued in patients with T2D, incretin-based therapies produced a favorable effect on traditional cardiovascular risk factors, such as lipids and blood pressure, and even reduced the risk of major cardiovascular events and heart failure-related events in individuals with obesity, as recently demonstrated for the first time in the SELECT trial with semaglutide 2.4 mg once-weekly
As always, confirm with your provider, who knows your full medication list and history